Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Snaith

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|June 30, 2022
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?Jennifer R Snaith, Jerry R Greenfield
Internal Medicine Journal|August 8, 2020
COVID-19: it's changed usJennifer R Snaith, Jerry R Greenfield
The New England Journal of Medicine|March 22, 2023
Once-Weekly Semaglutide in Adolescents with ObesityJennifer R Snaith, Jerry R Greenfield
The Medical Journal of Australia|February 28, 2021
Technologies in the management of type 1 diabetesJennifer R Snaith, D Jane Holmes-Walker
The Lancet. Gastroenterology & Hepatology|November 14, 2021
Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetesJennifer R Snaith, Mark Danta, Jerry R Greenfield
Touchreviews in Endocrinology|June 11, 2026
Beyond A1c: Redefining Evidence and Policy to Advance Therapies in Type 1 Diabetes CareHuajing Ni, Jerry R Greenfield, Jennifer R Snaith
Journal of Patient Experience|May 27, 2024
Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 DiabetesBella D Lamaro, Jerry R Greenfield, Jennifer R Snaith
Endocrinology, Diabetes & Metabolism Case Reports|January 12, 2021
Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomyJennifer R Snaith, Duncan McLeod, Arthur Richardson, et al.
Diabetes Care|July 24, 2019
Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2025
Use of Cardioprotective Adjuncts in Type 1 DiabetesJerry R Greenfield, Ruth Frampton, Kellie Millard, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|June 30, 2022
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?Jennifer R Snaith, Jerry R Greenfield
Internal Medicine Journal|August 8, 2020
COVID-19: it's changed usJennifer R Snaith, Jerry R Greenfield
The New England Journal of Medicine|March 22, 2023
Once-Weekly Semaglutide in Adolescents with ObesityJennifer R Snaith, Jerry R Greenfield
The Medical Journal of Australia|February 28, 2021
Technologies in the management of type 1 diabetesJennifer R Snaith, D Jane Holmes-Walker
The Lancet. Gastroenterology & Hepatology|November 14, 2021
Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetesJennifer R Snaith, Mark Danta, Jerry R Greenfield
Touchreviews in Endocrinology|June 11, 2026
Beyond A1c: Redefining Evidence and Policy to Advance Therapies in Type 1 Diabetes CareHuajing Ni, Jerry R Greenfield, Jennifer R Snaith
Journal of Patient Experience|May 27, 2024
Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 DiabetesBella D Lamaro, Jerry R Greenfield, Jennifer R Snaith
Endocrinology, Diabetes & Metabolism Case Reports|January 12, 2021
Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomyJennifer R Snaith, Duncan McLeod, Arthur Richardson, et al.
Diabetes Care|July 24, 2019
Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2025
Use of Cardioprotective Adjuncts in Type 1 DiabetesJerry R Greenfield, Ruth Frampton, Kellie Millard, et al.
Pageof 3